✦ LIBER ✦

Safety and pharmacokinetic study ofnab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non–small cell lung cancer

✍ Scribed by Isamu Okamoto, Nobuyuki Yamamoto, Kaoru Kubota, Yuichiro Ohe, Naoyuki Nogami, Haruyasu Murakami, Hidetoshi Yamaya, Katsuhiro Ono, Kazuhiko Nakagawa

Book ID: 113064524
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 161 KB
Volume: 30
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-011-9674-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Figitumumab combined with carboplatin an

Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer

✍ Yasushi Goto, Ikuo Sekine, Maki Tanioka, Takashi Shibata, Chiharu Tanai, Hajime 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 282 KB

Paclitaxel and Carboplatin plus Megestro

Paclitaxel and Carboplatin plus Megestrol acetate in advanced non-small cell lung cancer

✍ Thongprasert, S; Cheewakriangkrai, R; Eartongjit, J 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Gemictabine plus carboplatin in patients

Gemictabine plus carboplatin in patients with advanced non-small cell lung cancer

✍ Se Hoon Park; Seong Hwan Jeong; Sun Young Kyung; Young-Hee Lim; Chang Hyeok An; 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 77 KB

O-101 XYOTAX™/carboplatin vs paclitaxel/

O-101 XYOTAX™/carboplatin vs paclitaxel/carboplatin for the treatmentof PS2 patients with chemotherapy-naïve advanced non-small cell lung cancer (NSCLC): The stellar 3 phase III study

✍ Langer, C.; O'Byrne, K.; Ross, H.; Socinski, M.; Szczesna, A.; Dediu, M.; Orlov, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Phase I study of paclitaxel, carboplatin

Phase I study of paclitaxel, carboplatin and UFT in chemo-naive patients with advanced non-small cell lung cancer (NSCLC)

✍ Yasushi Ono; Mitsunori Hino; Yuka Ueda; Ryoko Kamizuru; Masatoshi Omata; Takashi 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 123 KB

A phase I pharmacokinetic study of bexar

A phase I pharmacokinetic study of bexarotene with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC)

✍ Jordi Rodon; Charlotte D. Jacobs; Quincy Chu; Eric K. Rowinsky; Arturo Lopez-Ana 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 277 KB